Home/Filings/4/0001415889-25-006709
4//SEC Filing

FITZPATRICK LINDA A 4

Accession 0001415889-25-006709

CIK 0001382101other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:40 PM ET

Size

14.1 KB

Accession

0001415889-25-006709

Insider Transaction Report

Form 4
Period: 2025-03-01
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-01+13,40093,227 total
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2025-03-016,87513,750 total
    Exp: 2027-03-01Common Stock (6,875 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-01+6,87579,827 total
  • Tax Payment

    Common Stock

    2025-03-01$1.59/sh8,327$13,24084,900 total
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2025-03-0113,40040,200 total
    Exp: 2028-03-01Common Stock (13,400 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    10,383
Footnotes (5)
  • [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
  • [F2]These securities are held of record by Michael A. Fitzpatrick and Linda A. Fitzpatrick, Trustees of the Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997.
  • [F3]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F4]The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
  • [F5]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date. Note that this transaction represents the aggregate vesting of RSU awards made on March 5, 2024 for 37,100 RSUs and on March 7, 2024 for 16,500 RSUs. The vesting events are reported on this Form 4 on an aggregate basis because both derivative instruments bear identical characteristics, including vesting schedules and expiration dates, and may be settled for the same class of security.

Issuer

SUTRO BIOPHARMA, INC.

CIK 0001382101

Entity typeother

Related Parties

1
  • filerCIK 0001188953

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:40 PM ET
Size
14.1 KB